Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Aytu BioPharma, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AYTU
Nasdaq
2830
aytubio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Aytu BioPharma, Inc.
Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
- Jan 13th, 2026 2:15 pm
Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City
- Jan 12th, 2026 6:00 am
Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City
- Dec 18th, 2025 7:00 am
Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults
- Dec 15th, 2025 7:00 am
Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference
- Nov 24th, 2025 2:05 pm
Positive Signs As Multiple Insiders Buy Aytu BioPharma Stock
- Nov 21st, 2025 5:40 am
Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Strong ADHD Portfolio Performance ...
- Nov 13th, 2025 10:02 pm
Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates
- Nov 13th, 2025 3:20 pm
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
- Nov 13th, 2025 2:05 pm
Astria Therapeutics, Inc. (ATXS) Reports Q3 Loss, Misses Revenue Estimates
- Nov 12th, 2025 7:10 am
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
- Nov 6th, 2025 3:35 pm
Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025
- Nov 5th, 2025 2:05 pm
Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)
- Oct 28th, 2025 7:00 am
Aytu BioPharma to Present at Upcoming October 2025 Conferences
- Oct 10th, 2025 7:00 am
11 Company Presentations Today at The MicroCap Rodeo Conference
- Sep 25th, 2025 6:00 am
Aytu BioPharma to Present at Upcoming September 2025 Conferences
- Sep 24th, 2025 2:15 pm
Aytu BioPharma Inc (AYTU) Q4 2025 Earnings Call Highlights: Strategic Moves and Financial ...
- Sep 24th, 2025 1:02 am
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
- Sep 23rd, 2025 2:05 pm
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
- Sep 16th, 2025 2:05 pm
Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Path To Profitability
- Aug 17th, 2025 6:25 am
Scroll